Scholar Rock Holding Corporation

$44.3 ▼ -2.27%
2026-06-06 10:46:00

Explore Scholar Rock Holding Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$5.31 B
Current Price
$44.3
52W High / Low
$52.19 / $27.07
Stock P/E
Book Value
$2.26
Dividend Yield
ROCE
-110.26%
ROE
-162.89%
Face Value
EPS
$-3.45
Exp Qtr EPS
Sector
Healthcare

SRRK — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.
  • Valuation is not stretched on P/E basis.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Regeneron Pharmaceuticals, Inc. $635.45 15.1 $66.78 B 0.6% 10.23% 14.32% $821.11 / $476.49 $295.71
2. Alnylam Pharmaceuticals, Inc. $303.05 70.37 $40.62 B 14.33% 98.29% $495.55 / $283.1 $5.96
3. Royalty Pharma plc $55.87 38.89 $32.17 B 1.71% 8.21% 12.67% $56.07 / $33.37 $11.22
4. Revolution Medicines, Inc. $149.23 $31.73 B -57.28% -54.06% $166.5 / $34 $8.28
5. Roivant Sciences Ltd. $28.58 $27.48 B -21.06% -6.85% $32.79 / $10.71 $6.28
6. Insmed Incorporated $94.22 $21.48 B -55.4% -130.11% $212.75 / $70.57 $3.45
7. Incyte Corporation $102.38 14.53 $20.8 B 24.67% 29.2% $112.29 / $66.74 $26.04

Quarterly Results

Figures shown in M / B

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales0 M0 M0 M0 M0 M
Operating Profit-91.9 M-103.55 M-112.11 M-77.09 M-69.36 M
Net Profit-90.97 M-102.22 M-110.03 M-74.72 M-66.45 M
EPS in Rs-0.79-0.89-0.96-0.65-0.58-0.66

Profit & Loss

Figures shown in M / B

2025202420232022
Sales0 M0 M0 M33.19 M
Operating Profit-384.64 M-252.05 M-171.29 M-134.37 M
Net Profit-377.94 M-246.29 M-165.79 M-134.5 M
EPS in Rs-3.29-2.14-1.44-1.17

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets404.27 M474.92 M311.04 M358.17 M
Total Liabilities158.78 M106.29 M85.82 M97.93 M
Equity245.49 M368.63 M225.22 M260.24 M
Current Assets385.15 M451.17 M288.19 M328.02 M
Current Liabilities55.42 M46.94 M32.74 M36.39 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF-300.04 M-200.95 M-145.23 M-132.69 M
Investing CF218.69 M-76.06 M41.14 M-171.7 M
Financing CF228.4 M353.03 M102.57 M194.83 M
Free CF-300.64 M-201.05 M-145.3 M-133.76 M
Capex-0.6 M-0.1 M-0.07 M-1.06 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2025202420232022
Revenue Growth %-100%
Earnings Growth %-53.45%-48.56%-23.26%
Profit Margin %-405.21%
Operating Margin %-404.81%
Gross Margin %
EBITDA Margin %-395.82%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund Mutual Fund 3.89 M $194.51 M 0.03% 2026-02-28
Fidelity Select Portfolios-Select Biotechnology Portfolio Mutual Fund 1.65 M $82.54 M 0.01% 2026-02-28
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund Mutual Fund 1.18 M $58.89 M 0.01% 2026-02-28
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund Mutual Fund 2.75 M $137.54 M 0.02% 2026-01-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF Mutual Fund 2.23 M $111.48 M 0.02% 2026-01-31
iShares Trust-iShares Russell 2000 ETF Mutual Fund 1.96 M $97.94 M 0.02% 2026-01-31
FMR, LLC Institutional 15.38 M $769.19 M 0.13% 2025-12-31
Siren, L.L.C. Institutional 10.83 M $541.36 M 0.09% 2025-12-31
Blackrock Inc. Institutional 7.22 M $360.92 M 0.06% 2025-12-31
Samsara BioCapital, LLC Institutional 6.9 M $344.95 M 0.06% 2025-12-31
Price (T.Rowe) Associates Inc Institutional 6.4 M $320.19 M 0.06% 2025-12-31
Wellington Management Group, LLP Institutional 5.76 M $288.03 M 0.05% 2025-12-31
Redmile Group, LLC Institutional 5.22 M $261.09 M 0.05% 2025-12-31
Vanguard Group Inc Institutional 5.2 M $259.83 M 0.05% 2025-12-31
Bellevue Group AG Institutional 4.06 M $202.87 M 0.04% 2025-12-31

Frequently Asked Questions — Scholar Rock Holding Corporation

Will Scholar Rock Holding Corporation stock hit $53 in 2026?

Scholar Rock Holding Corporation (SRRK) is currently trading at $44.30, with a 52-week range of $27.07 to $52.19. Reaching the $53 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $57.43 for Scholar Rock Holding Corporation, with a Strong_buy rating, and the most bullish analysts see the stock reaching as high as $70.0. Whether Scholar Rock Holding Corporation can reach $53 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Healthcare space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, SRRK has delivered a 12.0% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the SRRK Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Scholar Rock Holding Corporation stock worth buying at $44.30?

Whether Scholar Rock Holding Corporation (SRRK) is worth buying at $44.30 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Valuation data is currently limited — check the full ratios section on StockSifting for the latest P/E, P/B, and EV/EBITDA figures.

Profitability & efficiency: Scholar Rock Holding Corporation has a Return on Capital Employed (ROCE) of -110.3%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at -162.9%.

Financial health: The Debt-to-Equity ratio of 44.37 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for SRRK is currently Strong_buy, with a mean price target of $57.43 based on 14 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Scholar Rock Holding Corporation (SRRK) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $57.43 for Scholar Rock Holding Corporation (SRRK), aggregated from 14 analyst ratings. The overall analyst recommendation is Strong_buy.

The price target range spans from $48.0 on the bearish end to $70.0 on the most optimistic projection, with a median target of $58.0. This wide range reflects differing views on Scholar Rock Holding Corporation's growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the SRRK analysis page on StockSifting.

What will Scholar Rock Holding Corporation stock be worth in 2029?

Projecting Scholar Rock Holding Corporation (SRRK)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

Based on SRRK's historical 5-year Compound Annual Growth Rate (CAGR) of 12.0%, if that rate of growth were to continue, the stock could reach approximately $62 by 2029 — up from its current price of $44.30. This projection assumes the historical CAGR holds, which depends on Scholar Rock Holding Corporation sustaining its revenue growth, maintaining profit margins, and the market continuing to reward it at a similar valuation multiple.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the SRRK Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.